PharmAla Biotech Holdings, Inc. (TSE:MDMA) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
PharmAla Biotech Holdings Inc. has partnered with the University of Texas, San Antonio, to supply a unique dosage form of their proprietary LaNeo™ MDMA for a clinical trial. Additionally, the company has announced the publication of a patent application for APA-01, a new molecular entity, signaling growth in their intellectual property portfolio.
For further insights into TSE:MDMA stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue